Trials / Completed
CompletedNCT05298826
Recombinant Factor VII for Intractable Postpartum Haemorrhage
Recombinant Factor VII for the Conservative Management Trials of Intractable Postpartum Haemorrhage: is it a Drug Effect , Operator Experience or Inherent Result of the Aetiology.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 41 (actual)
- Sponsor
- Aljazeera Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Postpartum haemorrhage remains at the top of the causes of maternal deaths in both developed and developing countries .
Detailed description
Major postpartum haemorrhage is a dangerous complication that accounts for the highest maternal morbidity rate
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | recombinant factor VIIa | using recombinant factor VIIa |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2020-01-01
- Completion
- 2020-01-10
- First posted
- 2022-03-28
- Last updated
- 2022-03-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05298826. Inclusion in this directory is not an endorsement.